Published in Neuroscience on January 01, 2001
Adenosine A2A receptors and basal ganglia physiology. Prog Neurobiol (2007) 1.90
FGF acts as a co-transmitter through adenosine A(2A) receptor to regulate synaptic plasticity. Nat Neurosci (2008) 1.36
Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: implications for striatal neuronal function. Proc Natl Acad Sci U S A (2002) 1.30
Neurotransmitter receptor heteromers and their integrative role in 'local modules': the striatal spine module. Brain Res Rev (2007) 1.14
Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders. Curr Pharm Des (2008) 1.13
Selective inactivation of adenosine A(2A) receptors in striatal neurons enhances working memory and reversal learning. Learn Mem (2011) 1.01
ATP as a multi-target danger signal in the brain. Front Neurosci (2015) 0.94
GDNF control of the glutamatergic cortico-striatal pathway requires tonic activation of adenosine A receptors. J Neurochem (2009) 0.90
Regulation of fear responses by striatal and extrastriatal adenosine A2A receptors in forebrain. Biol Psychiatry (2013) 0.84
Presynaptic adenosine A2A receptors dampen cannabinoid CB1 receptor-mediated inhibition of corticostriatal glutamatergic transmission. Br J Pharmacol (2015) 0.82
Comorbidities in Neurology: Is adenosine the common link? Neuropharmacology (2015) 0.80
mGlu5 Receptor Functional Interactions and Addiction. Front Pharmacol (2012) 0.79
BDNF rescues BAF53b-dependent synaptic plasticity and cocaine-associated memory in the nucleus accumbens. Nat Commun (2016) 0.77
Postsynaptic adenosine A2A receptors modulate intrinsic excitability of pyramidal cells in the rat basolateral amygdala. Int J Neuropsychopharmacol (2015) 0.77
Evaluation of neuronal phosphoproteins as effectors of caffeine and mediators of striatal adenosine A2A receptor signaling. Brain Res (2006) 0.77
Adenosine A2A Receptors in the Amygdala Control Synaptic Plasticity and Contextual Fear Memory. Neuropsychopharmacology (2016) 0.75
Understanding the Functional Plasticity in Neural Networks of the Basal Ganglia in Cocaine Use Disorder: A Role for Allosteric Receptor-Receptor Interactions in A2A-D2 Heteroreceptor Complexes. Neural Plast (2016) 0.75
Disruption of the ATP/Adenosine Balance in CD39-/- Mice is Associated with Handling-Induced Seizures. Immunology (2017) 0.75
The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. J Biol Chem (2001) 4.77
Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. Nature (1997) 3.75
Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations. Eur J Neurosci (2000) 2.69
Metabotropic glutamate receptors drive the endocannabinoid system in hippocampus. J Neurosci (2001) 2.48
Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. J Neurosci (2001) 2.15
Nitric oxide synthase activity in infantile hypertrophic pyloric stenosis. N Engl J Med (1992) 2.14
Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus. Neuroscience (2001) 2.05
Primary structure of bovine thyroglobulin deduced from the sequence of its 8,431-base complementary DNA. Nature (1985) 1.96
Expression of members of the putative olfactory receptor gene family in mammalian germ cells. Nature (1992) 1.79
The orphan receptor cDNA RDC7 encodes an A1 adenosine receptor. EMBO J (1991) 1.57
A pitfall in the computer-aided quantitation of autoradiograms. Trends Biochem Sci (1989) 1.57
Context-dependent effects of CB1 cannabinoid gene disruption on anxiety-like and social behaviour in mice. Eur J Neurosci (2004) 1.55
The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety. Eur J Neurosci (2002) 1.52
Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse. Behav Brain Res (2001) 1.46
An update on adenosine A2A-dopamine D2 receptor interactions: implications for the function of G protein-coupled receptors. Curr Pharm Des (2008) 1.43
The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A(2A) receptors. Br J Pharmacol (2000) 1.42
Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas. Endocrinology (1996) 1.42
CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents. Behav Pharmacol (2004) 1.34
CD34 immunoreactivity and interstitial cells of Cajal in the human and mouse gastrointestinal tract. Cell Tissue Res (2000) 1.30
Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors. Proc Natl Acad Sci U S A (2000) 1.30
Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence. Neuropharmacology (2002) 1.29
Cocaine, but not morphine, induces conditioned place preference and sensitization to locomotor responses in CB1 knockout mice. Eur J Neurosci (2000) 1.25
Galpha(olf) levels are regulated by receptor usage and control dopamine and adenosine action in the striatum. J Neurosci (2001) 1.20
Enhancement of memory in cannabinoid CB1 receptor knock-out mice. Eur J Pharmacol (1999) 1.19
CD34+ cells in human intestine are fibroblasts adjacent to, but distinct from, interstitial cells of Cajal. Lab Invest (1999) 1.19
Rapid filtration studies of the effect of cytosolic Ca2+ on inositol 1,4,5-trisphosphate-induced 45Ca2+ release from cerebellar microsomes. J Biol Chem (1994) 1.18
Size determination of an equilibrium enzymic system by radiation inactivation: theoretical considerations. Biochem J (1982) 1.16
Hierarchical organization of calcium signals in hepatocytes: from experiments to models. Biochim Biophys Acta (2000) 1.16
Analysis of sequence and structure homologies between thyroglobulin and acetylcholinesterase: possible functional and clinical significance. Biochem Biophys Res Commun (1986) 1.16
Cellular distribution of the new growth factor pleiotrophin (HB-GAM) mRNA in developing and adult rat tissues. Anat Embryol (Berl) (1992) 1.16
The anxiogenic-like effect of caffeine in two experimental procedures measuring anxiety in the mouse is not shared by selective A(2A) adenosine receptor antagonists. Psychopharmacology (Berl) (2000) 1.13
Cannabinoids activate p38 mitogen-activated protein kinases through CB1 receptors in hippocampus. J Neurochem (2001) 1.11
The role of endogenous cannabinoids in the hypothalamo-pituitary-adrenal axis regulation: in vivo and in vitro studies in CB1 receptor knockout mice. Life Sci (2004) 1.11
Quantal release, incremental detection, and long-period Ca2+ oscillations in a model based on regulatory Ca2+-binding sites along the permeation pathway. Biophys J (1996) 1.11
Distribution and ultrastructure of interstitial cells of Cajal in the mouse colon, using antibodies to Kit and Kit(W-lacZ) mice. Cell Tissue Res (2000) 1.10
Post-translational modification of human brain type I inositol-1,4,5-trisphosphate 5-phosphatase by farnesylation. J Biol Chem (1996) 1.10
Somatic and germline mutations of the TSH receptor gene in thyroid diseases. J Clin Endocrinol Metab (1995) 1.05
Thyroperoxidase, an auto-antigen with a mosaic structure made of nuclear and mitochondrial gene modules. EMBO J (1987) 1.05
The central cannabinoid receptor inactivation suppresses endocrine reproductive functions. Biochem Biophys Res Commun (2001) 1.04
A2A receptor and striatal cellular functions: regulation of gene expression, currents, and synaptic transmission. Neurology (2003) 1.02
Functional characteristics of three new germline mutations of the thyrotropin receptor gene causing autosomal dominant toxic thyroid hyperplasia. J Clin Endocrinol Metab (1996) 1.02
Dopamine D3 receptor stimulation promotes the proliferation of cells derived from the post-natal subventricular zone. J Neurochem (2004) 1.00
Nitric oxide synthase distribution in the enteric nervous system of Hirschsprung's disease. Gastroenterology (1993) 1.00
Impaired long-term potentiation induction in dentate gyrus of calretinin-deficient mice. Proc Natl Acad Sci U S A (1997) 0.99
Identification of a cAMP-responsive region in thyroglobulin gene promoter. Mol Cell Endocrinol (1989) 0.99
Complete nucleotide sequence of the human thyroperoxidase-microsomal antigen cDNA. Nucleic Acids Res (1987) 0.98
Modulation of neuronal excitability by intracellular calcium buffering: from spiking to bursting. Cell Calcium (2006) 0.98
Anandamide degradation and N-acylethanolamines level in wild-type and CB1 cannabinoid receptor knockout mice of different ages. J Neurochem (2001) 0.97
Cloning and sequencing of a calcium-binding protein regulated by cyclic AMP in the thyroid. EMBO J (1989) 0.95
Mono- and dual-frequency fast cerebellar oscillation in mice lacking parvalbumin and/or calbindin D-28k. Eur J Neurosci (2005) 0.95
Protein kinase and cyclic 3',5'-AMP: significance of binding and activation constants. Biochim Biophys Acta (1974) 0.95
The human pregnancy-specific beta 1-glycoprotein (PS beta G) and the carcinoembryonic antigen (CEA)-related proteins are members of the same multigene family. Biochem Biophys Res Commun (1988) 0.95
Enhanced long-term potentiation in mice lacking cannabinoid CB1 receptors. Neuroscience (2000) 0.94
Caffeine reduces hypnotic effects of alcohol through adenosine A2A receptor blockade. Neuropharmacology (2003) 0.93
Adenosine A2A receptor antagonism and genetic deletion attenuate the effects of dopamine D2 antagonism on effort-based decision making in mice. Neuropharmacology (2012) 0.93
On the use of DNA fingerprints for linkage studies in cattle. Genomics (1990) 0.93
Thyroid pathologies in transgenic mice expressing a human activated Ras gene driven by a thyroglobulin promoter. Oncogene (1996) 0.92
The role of cyclic AMP and its effect on protein kinase A in the mitogenic action of thyrotropin on the thyroid cell. Ann N Y Acad Sci (2002) 0.92
Absence of the adenosine A(2A) receptor or its chronic blockade decrease ethanol withdrawal-induced seizures in mice. Neuropharmacology (2001) 0.91
Autoradiographic visualization of the receptor subclasses for vasoactive intestinal polypeptide (VIP) in rat brain. Peptides (1997) 0.90
Characterization of the co-agonist effects of strontium and calcium on myo-inositol trisphosphate-dependent ion fluxes in cerebellar microsomes. Cell Calcium (1995) 0.90
Adenosine A2A receptor antagonists are potential antidepressants: evidence based on pharmacology and A2A receptor knockout mice. Br J Pharmacol (2001) 0.89
Ca2+ oscillations in hepatocytes do not require the modulation of InsP3 3-kinase activity by Ca2+. FEBS Lett (2003) 0.89
Homology between thyroglobulin and acetylcholinesterase: an explanation for pathogenesis of Graves' ophthalmopathy? Lancet (1986) 0.88
A pitfall in the interpretation of data on ligand-protein interaction. Biochem J (1975) 0.88
Mechanism of receptor-oriented intercellular calcium wave propagation in hepatocytes. FASEB J (2000) 0.88
Lack of morphine-induced dopamine release in the nucleus accumbens of cannabinoid CB(1) receptor knockout mice. Eur J Pharmacol (1999) 0.88
Reduction of stress-induced analgesia but not of exogenous opioid effects in mice lacking CB1 receptors. Eur J Neurosci (2000) 0.88
Functional striatal hypodopaminergic activity in mice lacking adenosine A(2A) receptors. J Neurochem (2001) 0.87
Involvement of A2A receptors in anxiolytic, locomotor and motivational properties of ethanol in mice. Genes Brain Behav (2008) 0.86
Recombinant human papillomavirus type 16 E7 protein as a model antigen to study the vaccine potential in control and E7 transgenic mice. Clin Cancer Res (2001) 0.86
Cannabinoid CB1 receptor dependent effects of the NMDA antagonist phencyclidine in the social withdrawal model of schizophrenia. Behav Pharmacol (2005) 0.86
Specific ablation of thyroid follicle cells in adult transgenic mice. Endocrinology (1991) 0.86
Behavioural and biochemical responses to morphine associated with its motivational properties are altered in adenosine A(2A) receptor knockout mice. Br J Pharmacol (2008) 0.85
Caffeine-mediated induction of c-fos, zif-268 and arc expression through A1 receptors in the striatum: different interactions with the dopaminergic system. Eur J Neurosci (1999) 0.85
Distribution of SV2C mRNA and protein expression in the mouse brain with a particular emphasis on the basal ganglia system. Brain Res (2010) 0.85
Acute and chronic caffeine administration differentially alters striatal gene expression in wild-type and adenosine A(2A) receptor-deficient mice. Synapse (2001) 0.85
Presence of hormonogenic and repetitive domains in the first 930 amino acids of bovine thyroglobulin as deduced from the cDNA sequence. Eur J Biochem (1985) 0.85
Calretinin expression as a critical component in the control of dentate gyrus long-term potentiation induction in mice. Eur J Neurosci (1998) 0.84
Dual role of Fyn in the regulation of FAK+6,7 by cannabinoids in hippocampus. J Biol Chem (2001) 0.84
Early occurrence of metastatic differentiated thyroid carcinomas in transgenic mice expressing the A2a adenosine receptor gene and the human papillomavirus type 16 E7 oncogene. Oncogene (1996) 0.84
Binding assay for thyrotropin receptor autoantibodies using the recombinant receptor protein. J Clin Endocrinol Metab (1992) 0.83
Comparative study of hippocampal neuronal loss and in vivo binding of 5-HT1a receptors in the KA model of limbic epilepsy in the rat. Epilepsy Res (2001) 0.83
Analysis of expression of cholecystokinin in dopamine cells in the ventral mesencephalon of several species and in humans with schizophrenia. Proc Natl Acad Sci U S A (1990) 0.83
SCH 58261 and ZM 241385 differentially prevent the motor effects of CGS 21680 in mice: evidence for a functional 'atypical' adenosine A(2A) receptor. Eur J Pharmacol (2000) 0.83
Role of calcium binding proteins in the control of cerebellar granule cell neuronal excitability: experimental and modeling studies. Prog Brain Res (2005) 0.83
A2A adenosine receptor deficiency leads to impaired tracheal relaxation via NADPH oxidase pathway in allergic mice. J Pharmacol Exp Ther (2009) 0.83
HMGI-C gene expression is not required for in vivo thyroid cell transformation. Carcinogenesis (2001) 0.83
Kinetics of thyrotropin-stimulating hormone (TSH) and thyroid-stimulating antibody binding and action on the TSH receptor in intact TSH receptor-expressing CHO cells. J Clin Endocrinol Metab (2003) 0.82
Presynaptic adenosine A2A receptors dampen cannabinoid CB1 receptor-mediated inhibition of corticostriatal glutamatergic transmission. Br J Pharmacol (2015) 0.82
Studies with recombinant autoepitopes of thyroid peroxidase: evidence suggesting an epitope shared between the thyroid and the gastric parietal cell. Autoimmunity (1990) 0.82
The SH2 domain-containing 5-phosphatase SHIP2 is expressed in the germinal layers of embryo and adult mouse brain: increased expression in N-CAM-deficient mice. Neuroscience (2001) 0.82
Human papilloma virus 16 E7 oncogene does not cooperate with RET/PTC 3 oncogene in the neoplastic transformation of thyroid cells in transgenic mice. Oncol Res (2001) 0.82
Genetic interdependence of adenosine and dopamine receptors: evidence from receptor knockout mice. Neuroscience (2006) 0.82
Adenosine A2A receptor knockout mice are partially protected against drug-induced catalepsy. Neuroreport (2001) 0.82
Identification of hormonogenic domains in the carboxyl terminal region of bovine thyroglobulin. Biochem Biophys Res Commun (1984) 0.82